| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 645.80M | 579.40M | 521.70M | 484.60M | 447.70M |
| Gross Profit | 308.20M | 300.30M | 235.90M | 220.50M | 201.40M |
| EBITDA | 101.50M | 129.70M | 103.30M | 106.00M | 95.50M |
| Net Income | 64.90M | 69.80M | 53.60M | 49.30M | 53.60M |
Balance Sheet | |||||
| Total Assets | 621.30M | 528.00M | 474.80M | 406.80M | 361.80M |
| Cash, Cash Equivalents and Short-Term Investments | 23.70M | 153.70M | 136.50M | 94.60M | 52.80M |
| Total Debt | 50.60M | 7.90M | 11.70M | 13.20M | 15.20M |
| Total Liabilities | 236.30M | 155.30M | 130.60M | 107.10M | 107.60M |
| Stockholders Equity | 385.80M | 372.50M | 345.10M | 301.10M | 258.70M |
Cash Flow | |||||
| Free Cash Flow | 82.90M | 73.70M | 85.20M | 64.70M | 59.30M |
| Operating Cash Flow | 87.70M | 92.90M | 108.20M | 85.40M | 76.10M |
| Investing Cash Flow | -169.00M | -27.50M | -40.90M | -30.40M | -66.00M |
| Financing Cash Flow | -49.80M | -47.60M | -25.20M | -13.70M | -11.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | £21.05B | 22.16 | 5.29% | 4.42% | -2.53% | 24.52% | |
67 Neutral | £661.78M | 13.30 | 13.77% | 2.23% | 11.95% | 20.69% | |
63 Neutral | £26.65B | 7.41 | -8.37% | 3.74% | 16.15% | -279.78% | |
63 Neutral | £12.88B | 24.62 | 20.03% | 1.50% | 14.13% | ― | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
57 Neutral | £3.94B | ― | -35.13% | ― | ― | ― | |
44 Neutral | £18.31M | -9.06 | -2.48% | ― | -2.66% | 86.10% |